Abstract Background Adalimumab-aqvh/CHS-1420 (YUSIMRYTM) (hereafter referred to as adalimumab-aqvh) was recently approved by the US Food and Drug Administration as a biosimilar for adalimumab. Objective The current study was conducted to investigate the analytical similarity of adalimumab-aqvh and the reference product. adalimumab. Methods The structural. https://bbmbatteryes.shop/product-category/141/